Related Experiment Video
Updated: May 22, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Angiotensin II differentially regulates Morg1 expression in kidney cells
Tzvetanka Bondeva1, Juliane Heinzig, Sybille Franke
1Department of Internal Medicine III, Friedrich Schiller University, Jena, Germany.
American Journal of Nephrology
|May 5, 2012
Summary
Angiotensin II (ANG II) differentially regulates Morg1 expression and hypoxia-inducible factor-1α (HIF-1α) activity in kidney cells, revealing new insights into renal disease mechanisms.
Area of Science:
- Renal Cell Biology
- Molecular Signaling Pathways
- Kidney Disease Pathogenesis
Background:
- Mitogen-activated protein kinase organizer 1 (Morg1) is a WD-40 repeat protein and scaffold for ERK signaling.
- Morg1 stabilizes prolyl-hydroxylase 3 (PHD3), influencing hypoxia-inducible factor-1α (HIF-1α) expression.
- Angiotensin II (ANG II) is implicated in renal damage, with prior evidence of its effect on PHD3.
Purpose of the Study:
- To investigate whether ANG II regulates Morg1 expression in mouse mesangial cells (MMC), proximal tubular cells (MTC), and differentiated podocytes.
- To explore the correlation between Morg1 expression and PHD3 activity in these renal cell types.
- To elucidate the cell-specific mechanisms of ANG II action on Morg1 and HIF-1α.
Main Methods:
- Real-time PCR to assess Morg1 mRNA expression levels following ANG II treatment.
- Immunohistochemistry for Morg1 and HIF-1α cellular localization.
- Reporter gene assays for HIF-1α promoter activity and hydroxylation-coupled decarboxylation assays for PHD3 activity.
Main Results:
- ANG II exhibited biphasic and time-dependent regulation of Morg1 mRNA expression in MMC and MTC.
- ANG II signaling occurred via AT(1) receptors in MMC and AT(2) receptors in MTC.
- PHD3 activity correlated with Morg1 expression patterns; HIF-1α transcriptional activity showed varied correlations with PHD3 activity across cell types.
Conclusions:
- ANG II modulates Morg1 expression and HIF-1α transcriptional activity through cell type-specific mechanisms in renal cells.
- This study reveals a novel pathway by which ANG II may contribute to the development of renal disease.
- Findings highlight the complex interplay between Morg1, PHD3, and HIF-1α in mediating renal cellular responses to ANG II.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...